ACUTE ALLERGIC CONJUNCTIVITIS
Tags: CONJUNCTIVITIS; ALLERGY; POLLEN; EYE -- Inflammation; SYMPTOMS; ITCHING
Related Articles
- UPDATE ON OCULAR ALLERGIES IN ADULTS. Raizman, Michael B. // Ophthalmology Times;5/1/2007 New Paradigms in the Treat, Vol. 32, p5
The article provides information on topics related to ocular allergies in adults. Seasonal allergic conjunctivitis (SAC) is caused by exposure to airborne pollens from grasses, hay, weeds, and trees. Based on the history and clinical findings, the diagnosis of SAC is usually straightforward ....
- Allergy Challenge Series. Kabat, Alan G. // Review of Optometry;9/15/2004, Vol. 141 Issue 9, p54
Part III. Looks at the signs and symptoms of allergic conjunctivitis. Ocular itching; Ocular redness; Lid swelling; Chemosis; Tearing.
- Pemirolast for Allergic Conjunctivitis. Preboth, Monica // American Family Physician;10/1/2000, Vol. 62 Issue 7, p1707
Reports on the approval of pemirolast potassium ophthalmic solution 0.1 percent, a new ocular allergy medication indicated for the prevention of itching associated with allergic conjunctivitis, by the United States Food and Drug Administration. Description of pemirolast; How the drug performed...
- ALLERGIC conjunctivitis TREATMENT. // Optometry Times;Mar2009, Vol. 1 Issue 1, Special section p1
The article presents information on the clinical challenges and strategies for treating allergic conjunctivitis. A brief overview is given on the incidence of allergic conjunctivitis in the U.S. The characteristic clinical signs of the eye disorder include ocular itching, chemosis, watery or...
- Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts. Brehler, Randolf; Klimek, Ludger; Pfaar, Oliver; Hauswald, Bettina; Worm, Margitta; Bieber, Thomas // Allergy & Asthma Proceedings;May/Jun2010, Vol. 31 Issue 3, p31
Conventional subcutaneous immunotherapy (SCIT) for allergy treatment needs several injections over several weeks to reach the maintenance dose. Shorter up-dosing regimens are desired but limited by the potential of side effects. This study was designed to compare the safety of Depigoid...
- Ocular Allergy. Abelson, Mark B.; Fink, Kate // Review of Optometry;4/15/2005 Supplement, Vol. 142, p20
Focuses on the mechanism of the allergic reaction and the signs and symptoms of allergy suffered by individuals in the U.S. Differences in the timing of allergy seasons and the type of allergens present at different regions in the country; Description of ocular allergy; Growth in the problem of...
- Effective ocular allergy treatments are dual action. Torkildsen, Gail // Ophthalmology Times;4/1/2006, Vol. 31 Issue 7, p16
The article talks about the effective treatment of allergic conjunctivities. The anti-allergy dual-action agents have provided immediate, long-lasting relief from the signs and symptoms of allergic conjunctivitis. Signs and symptoms of common types of allergic conjunctivities include itching,...
- Corticosteroid provides potent, safe ocular allergy control. Devgan, Uday; Slonim, Charles B. // Ophthalmology Times;4/1/2006, Vol. 31 Issue 7, p24
The article indicates that loteprednol etabonate is a valuable therapeutic option for both short-and- longer-term management of allergic conjunctivitis. The efficacy of loteprednol etabonate for providing rapid and sustained control of allergic signs and symptoms in patients with seasonal...
- Agent's activity profile targets ocular allergy symptoms. Rosenwasser, Lanny J. // Ophthalmology Times;4/1/2006, Vol. 31 Issue 7, p26
The article presents comparative studies which show that Olopatadine HCI offers a unique pharmacologic profile of activity that corresponds to its unsurpassed efficacy in the management of allergic conjunctivitis. Preclinical studies reveal that olopatadine has some unique effects on...
